Lung Cancer Trial, Recruiting (NCT06945120)

Lung Cancer Trial, Recruiting NCT06945120 Sponsor: Dana-Farber Cancer Institute Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06945120 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who identify as Chinese or Korean.
People who speak Korean, Mandarin, or English.
People who are 18 years of age or older.
People who are current smokers, meaning they have smoked at least 100 traditional cigarettes in their lifetime and have smoked at least one traditional cigarette in the past 30 days.
People who plan to live in the United States for the next 12 months.

Who may not be able to join:

People who have been hospitalised due to a serious mental illness (such as a psychotic disorder) in the past 6 months.
People who are not able to give their own consent to participate.
People who are younger than 50 or older than 80 years of age (confirm with trial site, as this appears to conflict with the general age requirement of 18 and above).
People who are under 18 years of age, including infants, children, and teenagers.
People who are currently pregnant.
People who are currently in prison.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mary Cooley, PhD, Dana-Farber Cancer Institute

Phone: 617-632-5096

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06945120

Sponsor: Dana-Farber Cancer Institute

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

Trial contact: 617-632-5096

More information: https://clinicaltrials.gov/study/NCT06945120

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who identify as Chinese or Korean.
People who speak Korean, Mandarin, or English.
People who are 18 years of age or older.
People who are current smokers, meaning they have smoked at least 100 traditional cigarettes in their lifetime and have smoked at least one traditional cigarette in the past 30 days.
People who plan to live in the United States for the next 12 months.

Who may not be able to join:

People who have been hospitalised due to a serious mental illness (such as a psychotic disorder) in the past 6 months.
People who are not able to give their own consent to participate.
People who are younger than 50 or older than 80 years of age (confirm with trial site, as this appears to conflict with the general age requirement of 18 and above).
People who are under 18 years of age, including infants, children, and teenagers.
People who are currently pregnant.
People who are currently in prison.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Dana-Farber Cancer Institute

Registry

ClinicalTrials.gov

Start date

4 November 2025

Est. completion

30 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Biochemically Verified 7-Day Point Prevalence Smoking Abstinence at 6 Months (Group A); Biochemically Verified 7-Day Point Prevalence Smoking Abstinence at 6 Months (Group B)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov